Steps to redressing an imbalance: GLP-1 analogues for obesity in east Asia

Lancet Diabetes Endocrinol. 2022 Mar;10(3):153-154. doi: 10.1016/S2213-8587(22)00038-9. Epub 2022 Feb 4.

Authors

Tricia M-M Tan¹, Bernard Khoo²

Affiliations

¹ Department of Metabolism, Digestion and Reproduction, Imperial College London, London W12 0HS, UK. Electronic address: t.tan@imperial.ac.uk.
² Endocrinology, Division of Medicine, University College London, London, UK.

PMID: 35131036
DOI: 10.1016/S2213-8587(22)00038-9

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Comment

MeSH terms

Asia, Eastern / epidemiology
Glucagon-Like Peptide 1*
Humans
Hypoglycemic Agents*
Obesity / epidemiology

Substances

Hypoglycemic Agents
Glucagon-Like Peptide 1

Grants and funding

DH_/Department of Health/United Kingdom